Market Cap: $159.91M
CI
Coherus Oncology, Inc.
CHRS
NASDAQ (NASDAQ Global Market)USD
Market Cap: $159.91M
Coherus Biosciences Solidifies Its Position in Oncology with Strong Q4 Performance Coherus Biosciences demonstrates robust financial health in its Q4 earnings report released on March 9, 2026. The com…
Coherus Biosciences: Leveraging Innovation Amid Financial Fluctuations Coherus Biosciences, a biopharmaceutical company specializing in the development and commercialization of innovative therapeutics…
Coherus Biosciences: Focusing on Future Growth Amid a Competitive Landscape As the biopharmaceutical industry continues to evolve, the performance of companies like Coherus Biosciences becomes increas…
Navigating the Future of Biosimilars: Coherus BioSciences' Strategic Focus Coherus BioSciences is on the verge of releasing its latest quarterly earnings report, a development that sheds light on the…
Coherus BioSciences: Pioneering Growth in Biosimilars Amid Financial Anticipation Coherus BioSciences is set to unveil its quarterly earnings report on March 9, 2026, and anticipation surrounding the…
Revolutionizing Cancer Treatment: GT Biopharma's Innovative Approach GT Biopharma, Inc., a clinical-stage immuno-oncology company, is pioneering a transformative movement in precision medicine, which…
Coherus BioSciences Prepares for Key Earnings Announcement Amid Pipeline Advancements Coherus BioSciences is poised to reveal its quarterly earnings on November 6, 2025, an event that could significan…
Coherus BioSciences Prepares for Key Quarterly Earnings Announcement As Coherus BioSciences approaches its quarterly earnings report scheduled for November 6, 2025, the biopharmaceutical company is at…
Coherus Biosciences Captures Attention in Dynamic Biotech Landscape Coherus Biosciences stands at the forefront of a rapidly evolving biotechnology sector, which is currently experiencing a surge in i…
Coherus BioSciences Prepares for Key Earnings Report Amid Industry Challenges Coherus BioSciences (CHRS) stands on the brink of releasing its quarterly earnings report on August 7, 2025, a development…
Coherus BioSciences Prepares for Key Earnings Report Amid Industry Challenges Coherus BioSciences is on the brink of releasing its quarterly earnings report on August 7, 2025. This report is highly an…